Antioxidants as therapies: Can we improve on nature?

Free Radical Biology and Medicine

Volumn 66, Issue , 2014, Pages 20-23

  Murphy, Michael P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Antioxidant; Drug development; Free radicals; Oxidative damage; Pharmacology

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

BIOCHEMISTRY; CELL ORGANELLE; DETOXIFICATION; DRUG DESIGN; DRUG EFFICACY; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

ANTIOXIDANT; DRUG DEVELOPMENT; FREE RADICALS; OXIDATIVE DAMAGE; PHARMACOLOGY;

ANIMALS; ANTIOXIDANTS; CLINICAL TRIALS AS TOPIC; DRUG DESIGN; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84892368437     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.04.010     Document Type: Review

References (24)

1. B. Halliwell Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97 2006 1634 1658 (Pubitemid 43873658)
2. T. Finkel Opinion: radical medicine: treating ageing to cure disease Nat. Rev. Mol. Cell. Biol. 6 2005 971 976 (Pubitemid 41778716)
3. R.S. Balaban, S. Nemoto, and T. Finkel Mitochondria, oxidants, and aging Cell 120 2005 483 495 (Pubitemid 40269763)
4. B. Halliwell, J.M.C. Gutteridge, and C.E. Cross Free radicals, antioxidants, and human disease: where are we now? J. Lab. Clin. Med. 119 1992 598 620
5. G. Bjelakovic, D. Nikolova, L.L. Gluud, R.G. Simonetti, and C. Gluud Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases Cochrane Database Syst. Rev. 3 2012 CD007176
6. T. Iannitti, and B. Palmieri Antioxidant therapy effectiveness: an up to date Eur. Rev. Med. Pharmacol. Sci. 13 2009 245 278
7. S. Ueda, and K. Yasunari What we learnt from randomized clinical trials and cohort studies of antioxidant vitamin? Focus on vitamin E and cardiovascular disease Curr. Pharm. Biotechnol. 7 2006 69 72 (Pubitemid 44110352)
8. B. Halliwell The antioxidant paradox Lancet 355 2000 1179 1180 (Pubitemid 30172947)
9. M.P. Murphy, and L. Partridge Toward a control theory analysis of aging Annu. Rev. Biochem. 77 2008 777 798
10. J.M. Gutteridge, and B. Halliwell Antioxidants: molecules, medicines, and myths Biochem. Biophys. Res. Commun. 393 2010 561 564
11. S.E. Schriner, N.J. Linford, G.M. Martin, P. Treuting, C.E. Ogburn, M. Emond, P.E. Coskun, W. Ladiges, N. Wolf, H. Van Remmen, D.C. Wallace, and P.S. Rabinovitch Extension of murine life span by overexpression of catalase targeted to mitochondria Science 308 2005 1909 1911 (Pubitemid 40941874)
12. Y. Li, T.-T. Huang, E.J. Carlson, S. Melov, P.C. Ursell, J.L. Olson, L.J. Noble, M.P. Yoshimura, C. Berger, P.H. Chan, D.C. Wallace, and C.J. Epstein Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase Nat. Genet. 11 1995 376 381
13. B.N. Ames, M.K. Shigenaga, and T.M. Hagen Oxidants, antioxidants, and the degenerative diseases of aging Proc. Natl. Acad. Sci. USA 90 1993 7915 7922 (Pubitemid 23260825)
14. H.M. Cochemé, and M.P. Murphy Can antioxidants be effective therapeutics? Curr. Opin. Invest. Drugs 11 2010 426 431
15. M.P. Murphy, A. Holmgren, N.G. Larsson, B. Halliwell, C.J. Chang, B. Kalyanaraman, S.G. Rhee, P.J. Thornalley, L. Partridge, D. Gems, T. Nystrom, V. Belousov, P.T. Schumacker, and C.C. Winterbourn Unraveling the biological roles of reactive oxygen species Cell Metab. 13 2011 361 366
16. C.C. Winterbourn Reconciling the chemistry and biology of reactive oxygen species Nat. Chem. Biol. 4 2008 278 287
17. B. Halliwell, and M. Whiteman Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br. J. Pharmacol. 142 2004 231 255 (Pubitemid 38746160)
18. Y.M. Janssen-Heininger, B.T. Mossman, N.H. Heintz, H.J. Forman, B. Kalyanaraman, T. Finkel, J.S. Stamler, S.G. Rhee, and A. van der Vliet Redox-based regulation of signal transduction: principles, pitfalls, and promises Free Radic. Biol. Med. 45 2008 1 17
19. R.A. Smith, R.C. Hartley, H.M. Cochemé, and M.P. Murphy Mitochondrial pharmacology Trends Pharmacol. Sci. 33 2012 341 352
20. A.M. James, H.M. Cochemé, R.A. Smith, and M.P. Murphy Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species: implications for the use of exogenous ubiquinones as therapies and experimental tools J. Biol. Chem. 280 2005 21295 21312 (Pubitemid 40805692)
21. R. Zhao, and A. Holmgren A novel antioxidant mechanism of ebselen involving ebselen diselenide, a substrate of mammalian thioredoxin and thioredoxin reductase J. Biol. Chem. 277 2002 39456 39462 (Pubitemid 35190921)
22. R. Zhao, H. Masayasu, and A. Holmgren Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant Proc. Natl. Acad. Sci. USA 99 2002 8579 8584 (Pubitemid 34693604)
23. L. Kussmaul, and J. Hirst The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria Proc. Natl. Acad. Sci. USA 103 2006 7607 7612
24. J.D. Hayes, M. McMahon, S. Chowdhry, and A.T. Dinkova-Kostova Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway Antioxid. Redox Signaling 13 2010 1713 1748